Search hospitals > Nevada > Las Vegas

GenesisCare USA - Las Vegas

Claim this profile
Las Vegas, Nevada 89109
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Breast cancer
Conducts research for Pancreatic Cancer
116 reported clinical trials
2 medical researchers
Photo of GenesisCare USA - Las Vegas in Las VegasPhoto of GenesisCare USA - Las Vegas in Las VegasPhoto of GenesisCare USA - Las Vegas in Las Vegas

Summary

GenesisCare USA - Las Vegas is a medical facility located in Las Vegas, Nevada. This center is recognized for care of Lung Cancer, Cancer, Breast Cancer, Breast cancer, Pancreatic Cancer and other specialties. GenesisCare USA - Las Vegas is involved with conducting 116 clinical trials across 294 conditions. There are 2 research doctors associated with this hospital, such as John A. Ellerton and Alan K. Ikeda.

Area of expertise

1Lung Cancer
Global Leader
GenesisCare USA - Las Vegas has run 17 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage II
Stage III
2Cancer
Global Leader
GenesisCare USA - Las Vegas has run 15 trials for Cancer. Some of their research focus areas include:
Stage IV
PD-L1 positive
Stage II

Top PIs

Clinical Trials running at GenesisCare USA - Las Vegas

Bladder Cancer
Lung Cancer
Prostate Cancer
Esophageal cancer
Kidney Cancer
Bladder Carcinoma
Breast Cancer
Gastric cancer
Pancreatic Cancer
Cancer
Image of trial facility.

Eribulin + Chemotherapy

for Bladder Cancer

This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Image of trial facility.

Immunotherapy + Targeted Therapy

for Genitourinary Cancers

This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.
Recruiting1 award N/A9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at GenesisCare USA - Las Vegas?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security